1. Home
  2. SWBI vs SLDB Comparison

SWBI vs SLDB Comparison

Compare SWBI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith & Wesson Brands Inc.

SWBI

Smith & Wesson Brands Inc.

HOLD

Current Price

$15.21

Market Cap

688.3M

Sector

Industrials

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$6.87

Market Cap

759.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWBI
SLDB
Founded
1852
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
688.3M
759.8M
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
SWBI
SLDB
Price
$15.21
$6.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
11
Target Price
$14.00
$16.36
AVG Volume (30 Days)
386.4K
1.1M
Earning Date
06-17-2026
05-12-2026
Dividend Yield
3.37%
N/A
EPS Growth
N/A
34.97
EPS
0.05
N/A
Revenue
$474,661,000.00
$8,094,000.00
Revenue This Year
$7.61
N/A
Revenue Next Year
$3.72
N/A
P/E Ratio
$309.90
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$3.01
52 Week High
$15.79
$8.87

Technical Indicators

Market Signals
Indicator
SWBI
SLDB
Relative Strength Index (RSI) 54.53 46.21
Support Level $13.90 $6.58
Resistance Level $15.24 $6.97
Average True Range (ATR) 0.42 0.47
MACD 0.01 -0.06
Stochastic Oscillator 68.48 44.56

Price Performance

Historical Comparison
SWBI
SLDB

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: